HB

Heda Biomedical Industry Fund

Description

Heda Biomedical Industry Fund is an investment firm.

Investor Profile

Heda Biomedical Industry Fund has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B rounds (top funding stages).
  • Majority of deals are located in China.
  • Strong thematic focus on Biopharma, Biotechnology, Pharmaceutical.

Stage Focus

  • Series B (100%)

Country Focus

  • China (100%)

Industry Focus

  • Biopharma
  • Biotechnology
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Heda Biomedical Industry Fund frequently co-invest with?

CA
North America, Massachusetts, United States, Boston
Co-Investments: 1
VMS Asset Management
Asia, Hong Kong Island, Hong Kong, Hong Kong
Co-Investments: 1
Hillhouse Ventures
Asia, Central Region, Singapore, Singapore
Co-Investments: 1
SC
North America, Illinois, United States, Chicago
Co-Investments: 1
Oriental Fortune Capital
Asia, Guangdong, China, Shenzhen
Co-Investments: 1

What are some of recent deals done by Heda Biomedical Industry Fund?

BlissBio

Hangzhou, Zhejiang, China

Bliss Bio is a biopharmaceutical company focused on development of tumor targeting and immunotherapy drugs.

BiopharmaBiotechnologyPharmaceutical
Series BApr 16, 2021
Amount Raised: $61,341,226